Perenti Global : Ceasing to be a substantial holder from MS

Form 605

Corporations Act 2001

Section 671B

Notice of ceasing to be a substantial holder

To Company Name/Scheme

PERENTI GLOBAL LIMITED

ACN/ARSN

009 211 474

1.

Details of substantial holder (1)

Name

ACN/ARSN (if applicable)Morgan Stanley and its subsidiaries listed in Annexure A Not Applicable

The holder ceased to be a substantial holder on

March 25, 2022
The previous notice was given to the company on	March 28, 2022
The previous notice was dated	March 24, 2022
The holder became aware on	March 29, 2022

2.

Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities of the company orscheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

Date of change	Person whose relevant interest changed	Nature of change (4)	Consideration given in relation to change (5)	Class (6) and number of Securities affected	Person's votes affected
03/25/2022	Morgan Stanley & Co. International plc	Buy	14,268.75	18,899 Ordinary Shares	18,899
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	249.28	328 Ordinary Shares	328
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	47,646.68	62,693 Ordinary Shares	62,693
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	12,089.30	15,803 Ordinary Shares	15,803
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	117.81	154 Ordinary Shares	154
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	755.82	988 Ordinary Shares	988
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	4,305.40	5,665 Ordinary Shares	5,665
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	400.40	520 Ordinary Shares	520
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	1,934.31	2,562 Ordinary Shares	2,562
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	3.83	5 Ordinary Shares	5
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	565.88	752 Ordinary Shares	752
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	6,022.58	8,084 Ordinary Shares	8,084
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	25,679.41	34,469 Ordinary Shares	34,469
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	781.28	1,028 Ordinary Shares	1,028
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	235.56	312 Ordinary Shares	312
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	12,222.21	15,873 Ordinary Shares	15,873
03/25/2022	Morgan Stanley Australia Securities Limited	Buy	7.45	10 Ordinary Shares	10
03/25/2022	Morgan Stanley Australia Securities Limited	Sell	2,203.09	2,918 Ordinary Shares	2,918
03/25/2022	Morgan Stanley Australia Securities Limited	Sell	30,129.64	40,000 Ordinary Shares	40,000
03/25/2022	Morgan Stanley Australia Securities Limited	Sell	565.34	739 Ordinary Shares	739
03/25/2022	Morgan Stanley Australia Securities Limited	Sell	336.68	443 Ordinary Shares	443
03/25/2022	Morgan Stanley Australia Securities Limited	Sell	1,469.25	1,959 Ordinary Shares	1,959
03/25/2022	Morgan Stanley Australia Securities Limited	Sell	1,519.82	2,013 Ordinary Shares	2,013
03/25/2022	Morgan Stanley Australia Securities Limited	Sell	1,215.24	1,599 Ordinary Shares	1,599
03/25/2022	Morgan Stanley Australia Securities Limited	Sell	3,010.50	4,014 Ordinary Shares	4,014

03/25/2022

Morgan Stanley & Co. International plcCollateral ReturnedN/A

39,880,235 Ordinary Shares

39,880,235

3.

Changes in association

The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if applicable)	Nature of association
Not Applicable	Not Applicable

4.

Addresses

The addresses of persons named in this form are as follows:

Name	Address
Morgan Stanley	1585 Broadway, New York, New York, 10036, USA.
Morgan Stanley & Co. LLC	1585 Broadway, New York, 10036, USA.
Morgan Stanley & Co. International plc	Legal & Compliance Department, 25 Cabot Square, Canary Wharf, London, E14 4QA, UNITED KINGDOM.
Morgan Stanley Investment Management Inc.	522 5th Avenue, 6th Floor, New York, 10036, USA.
Morgan Stanley Australia Securities Limited	Level 39, Chifley Tower, 2 Chifley Square, Sydney, 2000, AUSTRALIA.

Signature

print name

sign here

Vice President

March 30, 2022

Annexure A

List of Morgan Stanley and its subsidiaries that have a relevant interest or deemed to have a relevant interest in the shares or units.

Name └─┬─Morgan Stanley ├─┬─Morgan Stanley International Holdings Inc.

• │ ├─┬─Morgan Stanley International Limited

• │ │ └─┬─Morgan Stanley Investments (UK)

• │ │ └───Morgan Stanley & Co. International plc

• │ └─┬─Morgan Stanley (Australia) Securities Holdings Pty Limited

• │ └───Morgan Stanley Australia Securities Limited └─┬─Morgan Stanley Capital Management, LLC └─┬─Morgan Stanley Domestic Holdings, Inc.

  ├───Morgan Stanley & Co. LLC └───Morgan Stanley Investment Management Inc.

Signature

print name

sign here

DIRECTIONS

• (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 4 of the form.

• (2) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

• (3) See the definition of "associate" in section 9 of the Corporations Act 2001.

• (4) Include details of:

  • (a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

  • (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

  See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

• (5) Details of the consideration must include any and all benefits, moneys and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

• (6) The voting shares of a company constitute one class unless divided into separate classes.

• (7) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.